US and Canada Beta Glucan Market Share,Insights, Potential Business Strategies, Revenue Analysis - 2027
Market Synopsis
Market Research Future speculates that the US & Canada beta glucan market is
predicted to demonstrate 6.1% CAGR (2016-2027)
owing to the prevalence of obesity among the consumers. Beta glucan is referred to as sugars which are found in
cell walls of fungi, bacteria, algae, yeasts, lichens, and plants, like barley
and oats. Beta glucans are consumed by mouth for high diabetes, cholesterol, HIV/AIDS,
cancer, canker sores, and high blood pressure. They are also consumed to boost
the immune system whose body defense has
been weakened by chronic fatigue syndrome, emotion, and physical stress, and by treatments such as chemotherapy or radiation.
Market Potential
and Pitfalls
Beta-glucans help to
improve and enhance the human immune system. People nowadays are becoming more
conscious and aware regarding healthy food intake and enhance their immune
system. Such factors have propelled the market growth for beta-glucan in the US & Canada market
throughout the assessment period. Interest for functional and nutraceutical
products is generally found in the recent decade owing to the quick way of
curing illness through the intake of food. Individuals across the world tend to
consume functional ingredients in order to fulfill their dietary requirements
as they affect the metabolic parameters positively and help to cure diseases like
diabetes, cancer, and cardiovascular diseases. Beta glucan is considered a
functional ingredient which consists of
several medical advantages. Such factors are highly contributing to the market
growth during the appraisal period. Beta glucans are essential nutrients which help to maintain proper functioning of the
immunity system. Consumers are becoming extremely aware regarding the benefits
of beta glucan which is contributing to the market growth. Moreover, the potential application of beta-glucans in food processing and personal
care sector is uplifting the growth of the market.
On the contrary, the shortage of major raw materials like molasses owing to their
increased application in industries and wine blending is considered to deter
the market growth throughout the appraisal period. The production of yeast is
highly dependent on molasses. The yeast market is facing competition from
industries for raw materials. The biofuel
sector is also threatened by the growth of the yeast market. With the high
availability of other substitutes, the beta-glucan
market is likely to hinder.
US & Canada
Beta Glucan Market: Segmental Analysis
The US & Canada beta glucan market has
been segmented on the basis of types, application, and functional type.
By mode of type, the US
& Canada beta glucan market share has been segmented into yeast extract
and yeast beta. Among these, the yeast extract is estimated to occupy a bigger
share in the market as it is used as a
natural catalyst in big-scale fermentation to make industrial ethanol, probiotics,
and nutritious dietary supplements.
By mode of application, the US & Canada
beta glucan market has been segmented into dairy products, beverages, bakery
& processed food, pharmaceuticals, and others. Among these, the beverage
and bakery & processed food segment are
considered to lead the segment owing to its extensive applications.
By mode of functionality, the US & Canada
beta glucan market has been segmented into soluble beta-glucan and insoluble
beta-glucan.
Regional Insights
Geographically, the US & Canada beta
glucan market span across regions namely, Canada and the US.
Considering the global scenario, Western Europe comprising on nations like Spain,
France, U.K, Italy, Germany, and others is predicted to dominate the beta
glucan market in US & Canada. Economies such as North America is presumed
to be the second-largest market in this region. The U.S. acquires the greater
part in the North American region. The growth is credited to the increasing
growth in population, rapid urbanization, and augmenting health awareness.
Also, the rising middle-class population is predicted to compel the market
growth in these regions.
Industry Updates
October 09, 2018: A growth-stage biotechnology
company focusing on the commercialization of active ingredients for the cosmetic
and healthcare sector, Ceapro Inc., has recently announced that it has received
its approval to initiate its comparison study. The study evaluates high-medium
molecular weight beta-glucan as add-on therapy to statins with hyperlipidemia from
Health Canada.
Competitive
Dashboard
The prominent players operating the US &
Canada beta glucan market are Lallemand,
Bio Springer, DSM USA, Super Beta glucan, Lesaffre USA, Cargill, ConAgra Foods
Inc, Tate & Lyle, Ceapro Inc, Alltech, Associated British Foods, Garuda
International Inc, Biothera Inc, and others.
NOTE: Our Team of Researchers are Studying
Covid19 and its Impact on Various Industry Verticals and wherever required we
will be considering Covid19 Footprints for Better Analysis of Market and
Industries. Cordially get in Touch for More Details
Comments
Post a Comment